Tags: drug | approval | diabetes | FDA

J&J Wins Approval for First in New Class of Diabetes Drugs

Friday, 29 Mar 2013 03:33 PM

Johnson & Johnson, the world’s largest seller of health-care products, won approval for the first in a new family of diabetes drugs for managing blood sugar.

The Food and Drug Administration cleared the drug known as canagliflozin to treat adults with Type 2 diabetes, the agency said today in a statement. The pill may generate $800 million in peak sales, Tony Butler, an analyst at Barclays Plc in New York, said in a telephone interview.

The FDA is requiring J&J to conduct five post-marketing studies of the once-a-day pill to be called Invokana. The studies will examine the cardiovascular risks of the drug, as well as monitor for malignancies and severe cases of pancreatitis, the FDA said.

© Copyright 2015 Bloomberg News. All rights reserved.

1Like our page

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved